Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma-Reference-Cited by-同舟云学术

Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma

Published:2019-02-20 Issue:1 Volume:24 Page:71-83
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Reyes Ismael¹,Reyes Niradiz¹²,Suriano Robert³,Iacob Codrin⁴,Suslina Nina⁴,Policastro Anthony¹,Moscatello Augustine¹,Schantz Stimson⁴,Tiwari Raj K.¹,Geliebter Jan¹

Affiliation:

1. Department of Microbiology and Immunology, New York Medical College, Valhalla, NY, USA

2. Genetics and Molecular Biology Research Group, University of Cartagena, Cartagena, Colombia

3. College of Mount Saint Vincent, Bronx, NY, USA

4. New York Eye and Ear Infirmary, New York, NY, USA

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference55 articles.

1. Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma, Cell 159 (2014), 676–690.

2. D. Anwesha, Adding automated Statistical Analysis and Biological Evaluation modules to www.arrayanalysis.org, Master, 2011.

3. TGF beta in prostate cancer: A growth inhibitor that can enhance tumorigenicity;Barrack;Prostate,1997

4. Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans;Bernfield;Annu Rev Cell Biol,1992

5. Expression of syndecan-1 in papillary carcinoma of the thyroid with extracapsular invasion;Bologna-Molina;Arch Med Res,2010

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Lipid Metabolism Disorders in the Development of Thyroid Cancer;International Journal of Molecular Sciences;2024-06-28

2. KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation;Biochemical Genetics;2024-02-05

3. The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications;Heliyon;2024-01

4. Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma;BMC Cancer;2022-11-04

5. Hyperemesis Gravidarum and the Potential for Cancer: A Longitudinal Cohort Study over Three Decades;Cancer Epidemiology, Biomarkers & Prevention;2022-07-15